The selective non-peptidic delta opioid agonist SNC80 does not facilitate intracranial self-stimulation in rats

European Journal of Pharmacology

Volumn 604, Issue 1-3, 2009, Pages 58-65

  Do Carmo, Gail Pereira ^a,c   Folk, John E ^b   Rice, Kenner C ^b   Chartoff, Elena ^a   Carlezon Jr , William A ^a   Negus, S Stevens ^a,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^c MARIST COLLEGE   (United States)

^d VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Amphetamine; Delta opioid receptor agonists; Intracranial self stimulation; SNC80; U69,593

Indexed keywords

4 [ALPHA (4 ALLYL 2,5 DIMETHYL 1 PIPERAZINYL) 3 METHOXYBENZYL] N,N DIETHYLBENZAMIDE; DELTA OPIATE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN DEPTH STIMULATION; CONTROLLED STUDY; CONVULSION; DOSE RESPONSE; DRUG ABUSE; DRUG EFFECT; DRUG MECHANISM; NONHUMAN; PRIORITY JOURNAL; RAT; SELF STIMULATION; STIMULUS RESPONSE;

ANIMALS; BEHAVIOR, ANIMAL; BENZAMIDES; BRAIN; ELECTRIC STIMULATION; OPIOID-RELATED DISORDERS; PIPERAZINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, DELTA; SEIZURES; SELF STIMULATION;

EID: 59249103996     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.12.021     Document Type: Article

References (53)

1. Berger B., Rothmaier A.K., Wedekind F., Zentner J., Feuerstein T.J., and Jackisch R. Presynaptic opioid receptors on noradrenergic and serotonergic neurons in the human as compared to the rat neocortex. Br. J. Pharmacol. 148 (2006) 795-806
2. Bespalov A., Lebedev A., Panchenko G., and Zvartau E. Effects of abused drugs on thresholds and breaking points of intracranial self-stimulation in rats. Eur. Neuropsychopharmacol. 9 (1999) 377-383
3. Bilsky E.J., Calderon S.N., Wang T., Bernstein R.N., Davis P., Hruby V.J., McNutt R.W., Rothman R.B., Rice K.C., and Porreca F. SNC 80, a selective, nonpeptidic and systemically active opioid delta agonist. J. Pharmacol. Exp. Ther. 273 (1995) 359-366
4. Bishop M.J., and McNutt R. Benzhydrylpiperazines as nonpeptidic delta opioid receptor ligands. In: Chang K.-J., Porreca F., and Woods J.H. (Eds). The Delta Receptor (2004), Marcel Dekker, New York, NY 113-138
5. Brandt M.R., Negus S.S., Mello N.K., Furness M.S., Zhang X., and Rice K.C. Discriminative stimulus effects of the nonpeptidic delta-opioid agonist SNC80 in rhesus monkeys. J. Pharmacol. Exp. Ther. 290 (1999) 1157-1164
6. Brandt M.R., Furness M.S., Mello N.K., Rice K.C., and Negus S.S. Antinociceptive effects of delta-opioid agonists in Rhesus monkeys: effects on chemically induced thermal hypersensitivity. J. Pharmacol. Exp. Ther. 296 (2001) 939-946
7. Brandt M.R., Furness M.S., Rice K.C., Fischer B.D., and Negus S.S. Studies of tolerance and dependence with the delta-opioid agonist SNC80 in rhesus monkeys responding under a schedule of food presentation. J. Pharmacol. Exp. Ther. 299 (2001) 629-637
8. Broom D.C., Guo L., Coop A., Husbands S.M., Lewis J.W., Woods J.H., and Traynor J.R. BU48: a novel buprenorphine analog that exhibits delta-opioid-mediated convulsions but not delta-opioid-mediated antinociception in mice. J. Pharmacol. Exp. Ther. 294 (2000) 1195-1200
9. Broom D.C., Jutkiewicz E.M., Folk J.E., Traynor J.R., Rice K.C., and Woods J.H. Convulsant activity of a non-peptidic delta-opioid receptor agonist is not required for its antidepressant-like effects in Sprague-Dawley rats. Psychopharmacology (Berl) 1641 (2002) 42-48
10. Calderon S.N., Rothman R.B., Porreca F., Flippen-Anderson J.L., McNutt R.W., Xu H., Smith L.E., Bilsky E.J., Davis P., and Rice K.C. Probes for narcotic receptor mediated phenomena. 19. Synthesis of (+)-4-[(alpha R)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3- methoxybenzyl]-N,N-diethylbenzamide (SNC 80): a highly selective, nonpeptide delta opioid receptor agonist. J. Med. Chem. 37 (1994) 2125-2128
11. Carlezon Jr. W.A., and Wise R.A. Microinjections of phencyclidine (PCP) and related drugs into nucleus accumbens shell potentiate medial forebrain bundle brain stimulation reward. Psychopharmacology (Berl) 128 (1996) 413-420
12. Carlezon Jr. W.A., and Chartoff E.H. Intracranial self-stimulation (ICSS) in rodents to study the neurobiology of motivation. Natl. Protoc. 2 (2007) 2987-2995
13. Carlezon Jr. W.A., Todtenkopf M.S., McPhie D.L., Pimentel P., Pliakas A.M., Stellar J.R., and Trzcinska M. Repeated exposure to rewarding brain stimulation downregulates GluR1 expression in the ventral tegmental area. Neuropsychopharmacology 25 (2001) 234-241
14. Devine D.P., and Wise R.A. Self-administration of morphine, DAMGO, and DPDPE into the ventral tegmental area of rats. J. Neurosci. 14 (1994) 1978-1984
15. Duvauchelle C.L., Fleming S.M., and Kornetsky C. Involvement of delta- and mu-opioid receptors in the potentiation of brain-stimulation reward. Eur. J. Pharmacol. 316 (1996) 137-143
16. Duvauchelle C.L., Fleming S.M., and Kornetsky C. DAMGO and DPDPE facilitation of brain stimulation reward thresholds is blocked by the dopamine antagonist cis-flupenthixol. Neuropharmacology 36 (1997) 1109-1114
17. Esposito R.U., Perry W., and Kornetsky C. Effects of d-amphetamine and naloxone on brain stimulation reward. Psychopharmacology (Berl) 69 (1980) 187-191
18. Fraser G.L., Pradhan A.A., Clarke P.B., and Wahlestedt C. Supraspinal antinociceptive response to [D-Pen(2,5)]-enkephalin (DPDPE) is pharmacologically distinct from that to other delta-agonists in the rat. J. Pharmacol. Exp. Ther. 295 (2000) 1135-1141
19. Gallantine E.L., and Meert T.F. A comparison of the antinociceptive and adverse effects of the mu-opioid agonist morphine and the delta-opioid agonist SNC80. Basic Clin. Pharmacol. Toxicol. 97 (2005) 39-51
20. Gallistel C.R., and Karras D. Pimozide and amphetamine have opposing effects on the reward summation function. Pharmacol. Biochem. Behav. 20 (1984) 73-77
21. Goeders N.E., Lane J.D., and Smith J.E. Self-administration of methionine enkephalin into the nucleus accumbens. Pharmacol. Biochem. Behav. 20 (1984) 451-455
22. Gross G.J., Fryer R.M., Patel H.H., and Schultz J.E.J. Cardioprotection and delta opioid receptors. In: Chang K.-J., Porreca F., and Woods J.H. (Eds). The Delta Receptor (2004), Marcel Dekker, New York, NY 451-466
23. Gutstein H., and Akil H. Opioid analgesics. In: Brunton L., Lazo J., and Parker K. (Eds). The Pharmacological Basis of Therapeutics (2005), McGraw-Hill, New York, NY 547-590
24. He L., and Lee N.M. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord. J. Pharmacol. Exp. Ther. 285 (1998) 1181-1186
25. Hille C.J., Fox S.H., Maneuf Y.P., Crossman A.R., and Brotchie J.M. Antiparkinsonian action of a delta opioid agonist in rodent and primate models of Parkinson's disease. Exp. Neurol. 172 (2001) 189-198
26. Hruby V., and Mosberg H.I. Endogenous peptides for delta opioid receptors and analogues. In: Chang K.-J., Porreca F., and Woods J.H. (Eds). The Delta Receptor (2004), Marcel Dekker, New York, NY 159-174
27. Jutkiewicz E.M., Baladi M.G., Folk J.E., Rice K.C., and Woods J.H. Antidepressant-like effects in delta opioid receptor agonists. In: Chang K.-J., Porreca F., and Woods J.H. (Eds). The Delta Receptor (2004), Marcel Dekker, New York, NY 355-372
28. Jutkiewicz E.M., Rice K.C., Traynor J.R., and Woods J.H. Separation of the convulsions and antidepressant-like effects produced by the delta-opioid agonist SNC80 in rats. Psychopharmacology (Berl) 182 (2005) 588-596
29. Jutkiewicz E.M., Baladi M.G., Folk J.E., Rice K.C., and Woods J.H. The convulsive and electroencephalographic changes produced by nonpeptidic delta-opioid agonists in rats: comparison with pentylenetetrazol. J. Pharmacol. Exp. Ther. 317 (2006) 1337-1348
30. Knapp R.J., Santoro G., De Leon I.A., Lee K.B., Edsall S.A., Waite S., Malatynska E., Varga E., Calderon S.N., Rice K.C., Rothman R.B., Porreca F., Roeske W.R., and Yamamura H.I. Structure-activity relationships for SNC80 and related compounds at cloned human delta and mu opioid receptors. J. Pharmacol. Exp. Ther. 277 (1996) 1284-1291
31. Longoni R., Spina L., Mulas A., Carboni E., Garau L., Melchiorri P., and Di Chiara G. (D-Ala2)deltorphin II: D1-dependent stereotypies and stimulation of dopamine release in the nucleus accumbens. J. Neurosci. 11 (1991) 1565-1576
32. Longoni R., Cadoni C., Mulas A., Di Chiara G., and Spina L. Dopamine-dependent behavioural stimulation by non-peptide delta opioids BW373U86 and SNC 80: 2. Place-preference and brain microdialysis studies in rats. Behav. Pharmacol. 9 (1998) 9-14
33. Mague S.D., Andersen S.L., and Carlezon Jr. W.A. Early developmental exposure to methylphenidate reduces cocaine-induced potentiation of brain stimulation reward in rats. Biol. Psychiatry 57 (2005) 120-125
34. Mansour A., Khachaturian H., Lewis M.E., Akil H., and Watson S.J. Anatomy of CNS opioid receptors. Trends Neurosci. 11 (1988) 308-314
35. Miliaressis E., Rompre P.P., Laviolette P., Philippe L., and Coulombe D. The curve-shift paradigm in self-stimulation. Physiol. Behav. 37 (1986) 85-91
36. Morales L., Perez-Garcia C., and Alguacil L.F. Effects of yohimbine on the antinociceptive and place conditioning effects of opioid agonists in rodents. Br. J. Pharmacol. 133 (2001) 172-178
37. Negus S.S., Butelman E.R., Chang K.-J., DeCosta B., Winger G., and Woods J.H. Behavioral effects of the systemically active delta opioid agonist BW373U86 in rhesus monkeys. J. Pharmacol. Exp. Ther. 270 (1994) 1025-1034
38. Negus S.S., Mello N.K., Portoghese P.S., Lukas S.E., and Mendelson J.H. Role of delta opioid receptors in the reinforcing and discriminative stimulus effects of cocaine in rhesus monkeys. J. Pharmacol. Exp. Ther. 273 (1995) 1245-1256
39. Negus S.S., Gatch M.B., Mello N.K., Zhang X., and Rice K. Behavioral effects of the delta-selective opioid agonist SNC80 and related compounds in rhesus monkeys. J. Pharmacol. Exp. Ther. 286 (1998) 362-375
40. Ossipov M.H., Lai J., Vanderah T.W., and Porecca F. The delta receptor subtypes and pain modulation. In: Chang K.-J., Porreca F., and Woods J.H. (Eds). The Delta Receptor (2004), Marcel Dekker, New York, NY 297-329
41. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates. second ed (1986), Academic Press, New York, NY
42. Perrine S.A., Hoshaw B.A., and Unterwald E.M. Delta opioid receptor ligands modulate anxiety-like behaviors in the rat. Br. J. Pharmacol. 147 (2006) 864-872
43. Schaefer G.J., and Michael R.P. An analysis of the effects of amphetamine on brain self-stimulation behavior. Behav. Brain Res. 29 (1988) 93-101
44. Shippenberg T.S., Bals-Kubik R., and Herz A. Motivational properties of opioids: evidence that an activation of delta-receptors mediates reinforcement processes. Brain Res. 436 (1987) 234-239
45. Spanagel R., Herz A., and Shippenberg T.S. The effects of opioid peptides on dopamine release in the nucleus accumbens: an in vivo microdialysis study. J. Neurochem. 55 (1990) 1734-1740
46. Spina L., Longoni R., Mulas A., Chang K.-J., and Di Chiara G. Dopamine-dependent behavioural stimulation by non-peptide delta opioids BW373U86 and SNC 80: 1. Locomotion, rearing and stereotypies in intact rats. Behav. Pharmacol. 9 (1998) 1-8
47. Todtenkopf M.S., Marcus J.F., Portoghese P.S., and Carlezon Jr. W.A. Effects of kappa-opioid receptor ligands on intracranial self-stimulation in rats. Psychopharmacology (Berl) 172 (2004) 463-470
48. Tomasiewicz H.C., Todtenkopf M.S., Chartoff E.H., Cohen B.M., and Carlezon Jr. W.A. The kappa-opioid agonist U69,593 blocks cocaine-induced enhancement of brain stimulation reward. Biol. Psychiatry 64 (2008) 982-988
49. Tzschentke T.M. Measuring reward with the conditioned place preference (CPP) paradigm. Addict. Biol. 12 (2007) 227-462
50. Wise R.A. Addictive drugs and brain stimulation reward. Annu. Rev. Neurosci. 19 (1996) 319-340
51. Wise R.A. Drug-activation of brain reward pathways. Drug Alcohol Depend. 51 (1998) 13-22
52. Wise R.A., and Bozarth M.A. Action of drugs of abuse on brain reward systems: an update with specific attention to opiates. Pharmacol. Biochem. Behav. 17 (1982) 239-243
53. Wise R.A., and Rompre P.P. Brain dopamine and reward. Annu. Rev. Psychol. 40 (1989) 191-225